From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

Explore the potential of monoclonal antibodies in Alzheimer’s treatment, including breakthroughs and challenges in this ...

Shares of solid tumor concern Zymeworks Inc. have barely budged since the company obtained its first approval. Click here to read why ZYME stock is a Hold.

Introduction Therapeutic antibodies are laboratory-engineered proteins designed to replicate the immune system's natural ability to combat dise ...

The European Commission (EC) has approved sugemalimab in combination with platinum-based chemotherapy for the first-line treatment of patients with metastatic NSCLC with no sensitizing EGFR mutations, ...

H.C. Wainwright analyst Andres Y. Maldonado confirmed a Buy rating and a $75.00 price target on Corbus Pharmaceuticals (NASDAQ:CRBP), representing significant upside potential from the current price ...

Some Indian CDMOs have witnessed a 50 per cent year-on-year increase in Requests for Proposals (RFPs) in 2024, as global pharmaceutical companies look to diversify supply chains beyond China. Indian ...

Biotechnology Market OverviewThe Biotechnology Market report delivers crucial insights into the market's growth trajectory ...

Accord BioPharma, Inc., the U.S. specialty division of Intas Pharmaceuticals, Ltd. ("Intas Pharmaceuticals"), focused on the development ...